Commentary|Podcasts|August 22, 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Ken Banta, founder and CEO of The Vanguard Network, reveals the mindsets and moves biopharma leaders need to not just endure—but rise above—the current age of industry disruption.

In a turbulent era for the life sciences, leadership demands clarity, resilience, and adaptability. In this candid podcast conversation with Pharm Exec, Ken Banta, founder and CEO of The Vanguard Network, shares high-level insights on what CEOs can do to thrive amid the disruption—from regulatory agility to cultural resilience. The corporate strategy expert and author of the new book Seeing Around Corners explains why the best leaders are the best learners—and how prioritization, honesty, and boldness will separate those who merely survive from those who shape the industry’s future.

Highlights of the interview include:

  • Navigating a “new maze” at the FDA and its personality-driven complexities
  • R&D bets shifting toward proven winners, leaving long-shot breakthroughs behind
  • Building trust and culture through transparency in uncertain times
  • The call for leaders to embrace continuous learning—from AI startups to lab bench innovators

Click below to listen. View/download the transcript here.


Related to this article

What Life Sciences CEOs Are Losing Sleep Over in 2026
A new benchmarking survey of 33 biotech and medtech leaders reveals a leadership community operating in crisis mode — and what that means for how the industry needs to rethink peer support, advisory and the isolation built intothe CEO role itself.